Revascularisation in diabetics with multivessel coronary artery disease.
作者信息
Beatt K J, Morgan K P, Kapur A
机构信息
Hammersmith Hospitals NHS Trust, Du Cane Road London, UK.
出版信息
Heart. 2004 Sep;90(9):999-1002. doi: 10.1136/hrt.2003.028852.
Abstract
摘要
相似文献
1
Revascularisation in diabetics with multivessel coronary artery disease.多支冠状动脉疾病糖尿病患者的血运重建
Heart. 2004 Sep;90(9):999-1002. doi: 10.1136/hrt.2003.028852.
2
Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease?对于患有多支冠状动脉疾病的糖尿病患者，手术仍然是冠状动脉血运重建的首选方案吗？
Heart. 2002 May;87(5):407-9. doi: 10.1136/heart.87.5.407.
3
[Percutaneous coronary intervention in patients with diabetes mellitus].[糖尿病患者的经皮冠状动脉介入治疗]
Ugeskr Laeger. 2003 Jan 6;165(2):111-5.
4
[Angioplasty or surgery in the patient with multivessel disease].[多支血管病变患者的血管成形术或手术]
Arch Mal Coeur Vaiss. 1999 Nov;92(11 Suppl):1617-26.
5
Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus.糖尿病患者多支冠状动脉疾病的血运重建策略
Heart. 2013 Nov;99(22):1633-5. doi: 10.1136/heartjnl-2013-303820. Epub 2013 Mar 8.
6
Revascularisation strategy for diabetic multivessel coronary arteriopathy.
J Indian Med Assoc. 2006 Apr;104(4):186, 188-9, 194.
7
The CARDia trial protocol.CARDia试验方案。
Heart. 2003 Oct;89(10):1125-6. doi: 10.1136/heart.89.10.1125.
8
[Bypass surgery vs angioplasty for coronary artery disease].[冠状动脉疾病的搭桥手术与血管成形术对比]
Rev Med Liege. 1999 Jul;54(7):593-9.
9
[Does diabetes affect therapy in coronary patients? Revascularisation].糖尿病是否影响冠心病患者的治疗？血管重建
Arch Mal Coeur Vaiss. 2004 Dec;97 Spec No 3:59-62.
10
Is surgery preferred for the diabetic with multivessel disease? Debate on revascularization strategy for diabetic patients with multivessel coronary artery disease.
Circulation. 2005 Sep 6;112(10):1507-13; discussion 1514.
本文引用的文献
1
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.雷帕霉素洗脱支架与标准支架治疗冠状动脉狭窄患者的比较
N Engl J Med. 2003 Oct 2;349(14):1315-23. doi: 10.1056/NEJMoa035071.
2
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.经皮冠状动脉介入治疗后早期持续双重口服抗血小板治疗：一项随机对照试验。
JAMA. 2002 Nov 20;288(19):2411-20. doi: 10.1001/jama.288.19.2411.
3
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.西罗莫司洗脱支架与标准支架用于冠状动脉血运重建的随机对照研究。
N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843.
4
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.冠状动脉搭桥手术与支架置入术治疗多支血管病变的比较。
N Engl J Med. 2001 Apr 12;344(15):1117-24. doi: 10.1056/NEJM200104123441502.
5
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
N Engl J Med. 2000 May 4;342(18):1316-24. doi: 10.1056/NEJM200005043421803.
6
Abciximab reduces mortality in diabetics following percutaneous coronary intervention.阿昔单抗可降低糖尿病患者经皮冠状动脉介入治疗后的死亡率。
J Am Coll Cardiol. 2000 Mar 15;35(4):922-8. doi: 10.1016/s0735-1097(99)00650-6.
7
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.优化糖尿病患者经皮介入治疗的效果：血小板IIb/IIIa抑制剂用于支架置入试验（EPISTENT）糖尿病亚组研究结果
Circulation. 1999;100(25):2477-84. doi: 10.1161/01.cir.100.25.2477.
8
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.糖尿病、糖蛋白IIb/IIIa阻滞剂与肝素：一项多中心试验中复杂相互作用的证据。EPILOG研究组。
Circulation. 1998 May 19;97(19):1912-20. doi: 10.1161/01.cir.97.19.1912.
9
10
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.多支血管病变患者冠状动脉搭桥手术与血管成形术的比较。
N Engl J Med. 1996 Jul 25;335(4):217-25. doi: 10.1056/NEJM199607253350401.
Zotero 插件